Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

HHD 2 > COPD > Flashcards

COPD Flashcards

1
Q

COPD is both a __________ and ____________ disease

A

restrictive and obstructive disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Airway diseases are ___________

A

obstructive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Lung diseases are ___________

A

restrictive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COPD constitutes the following diseases/disorders…

A

chronic bronchitis
emphysema

COPD refers to a group of lung diseases that causes difficulty with breathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In what ways does asthma differ from COPD ?
(biochemically?)

A

(later slide can be used)

reversibility with SABA
reversibility reflected with a reduction of eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List some symptoms of COPD

A

exertional breathlessness
chronic cough (reductive cough)
regular sputum production due to inflamed bronchi
frequent winter bronchitis
wheeze (can be occasional)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List some symptoms of COPD

A

exertional breathlessness
chronic cough (reductive cough)
regular sputum production due to inflamed bronchi
frequent winter bronchitis
wheeze (can be occasional)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Wheezing is a result of …

A

constriction of the airways
constriction of the bronchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COPD has no clinical features of asthma. True or false

A

True

?? Inspirational/expirational wheezing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the characteristic of COPD presentation?

A

chronic symptoms- persistent and non-episodic symptoms

smoking

non- atopic (atopy is a predisposition to autoimmune responses to antigens; eczema, asthma, hayfever)

daily productive cough (mucous production due to bronchitis)

progressive breathlessness

Frequent infective exarcebations

chronic bronchitis- leads to wheezing

Emphysema- breathless sounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What occurs in emphysema?

A

destruction of the alveoli/ air sacs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What assessments are required for COPD?

A

assess symptoms
assess the degree of flow limitation using spirometry (how much air goes in and out of the lungs)
assess the risk of exarcebations
assess comorbidities (heart disease, heart failure)

(assess effects on daily living)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is COPD diagnosed?

A

there is no single diagnostic test
diagnosis of COPD relies on clinical judgement

clinical judgement of medical history, physical examination and spirometry to measure airway obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Briefly outline the pathway for a COPD diagnosis

A
  • consider COPD diagnosis based on patient history
  • perform spirometry
  • if no doubt- diagnose and start treatment
  • reassess diagnosis in response to treatment
  • consider COPD diagnosis based on patient history
  • perform spirometry, if unlikely
    -if still in doubt consider additional pointers
  • provisional diagnosis, start empirical treatment
  • reassess diagnosis in view of response to treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can you determine if a patient has a high risk COPD? (note: not high risk of)

A

use history of exarcebations and spirometry

high risk COPD; associated symptoms are worse; even worse lung function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are indicators of high risk COPD?

A

two exarcebations or more withing the last yeaer
FEV1 < 50% of the predicted value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the most significant risk factor for COPD?

A

smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the hallmarks of COPD?

A

mucociliary damage (damage to lining of the bronchi)
inflammation (inflammation of bronchi)
tissue damage (alveoli and bronchi damage due to proteases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the characteristics of COPD?

A

exarcebations
reduced lung function (FEV1 <50% of predicted value)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the symptoms of COPD?

A

breathlessness
worsening quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What type of epithelium is the bronchi lined with ?

A

respiratory epithelium
pseudocolumnar epithelium whose function os to produce mucous

[cilia then sift the mucous into stomach (pH) or mouth (cough)]

the mucous sits on to of the respiratory epithelium that lines the bronchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the consequence of the destruction of functional cilia?

A

stagnant mucous - increases the risk of infection; non moving fluid always increases the chance of infection (e.g. urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Give examples of agents that can cause damage to the cilia?

A

H. influenzae
smoking (noxious agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Briefly outline the disease process in COPD

A

cigarette smoke

alveolar macrophage releases neutrophil chemotactic factors, cytokines (IL-8), mediators (LTB4), oxygen radicals

acute inflammatory cells are attracted to the site (alveoli)

neutrophil releases proteases

Proteases are involved in the destruction of the alveolar wall (emphysema)

Proteases leads to mucous hypersecretion (chronic bronchitis)

this all leads to progressive airflow limitation

(protease inhibitors not enough to inhibit the action of protease and minimise collateral damage to tissue)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

There is a ____________ imbalance in emphysema

A

protease (less anti-protease/protease inhibitor to minimise the effects)

There is also often a genetic predisposititon to not having enough anti-proteases and thus increasing the risk of developing emphysema
this therefore increases the ri

26
Q

What is the consequence of the destruction of emphysema?

A

impaired gas exchange
there is less available tissue to exchange CO2 and O2

27
Q

What are the hallmarks of chronic bronchitis?

A

chronic neutrophilic inflammation

mucous hypersecretion (due to damaged lining)

smooth muscle spasm and hypertrophy (bronchospasms; common symptom with asthma)

partially reversible

28
Q

What are the hallmarks of emphysema?

A

alveolar destruction

impaired gas exchange

loss of bronchial support

irreversible

29
Q

Briefly outline the chronic cascade in COPD

A

progressive fixed airflow obstruction

impaired alveolar gas exchange

respiratory failure - decrease in PaO2, increase in PaCO2

pulmonary hypertension

right ventricular hypertrophy/failure (cor pulmonale)

death

30
Q

What is the consequence of an increased PaCO2?

A

acidosis; change/decline in pH; enzymes are affected by this; cell metabolism is affected by this

31
Q

What is cor pulmonale? Why does it occur in COPD patients?

A

this is an abnormal enlargement of the right hand side of the heart as a result of diseases of the lungs or pulmonary vessels

occurs in COPD patients because more effort is required to pump blood lung that has all this scar tissue/damage

32
Q

According the COPD treatment algorithm, how should patients at risk of COPD (cough sputum) be treated?

A

avoidance of risk factors/influenza vaccine

33
Q

According the COPD treatment algorithm, how should patients with mild COPD (FVC<70, FEV >80% of predicted or no symptoms) be treated?

A

SABA (Short acting beta agonist)

34
Q

According the COPD treatment algorithm, how should patients with moderate IIA COPD(FEV1/FVC <70%, 50% FEV, <80% predicted, +/- symptoms) be treated?

A

Regular (1 or more) bronchodilators
rehabilitation

35
Q

According the COPD treatment algorithm, how should patients with moderate IIB COPD(FEV1/FVC <70%, =30% FEV, <80% predicted, +/- symptoms) be treated?

A

inhaled corticosteroids if it is a lung function response (alveoli)

36
Q

According the COPD treatment algorithm, how should patients with severe COPD(FEV1/FVC <70%, FEV, <30% predicted, presence of respiratory failure or right heart
failure) be treated?

A

inhaled corticosteroids if lung function response or if repeated exarcebations

treatment of complications, surgery, LTOT

LTOT-long term oxygen therapy

37
Q

Treatment of COPD is dependent…

A

the GOLD stage

GOLD 1 - mild: FEV1 ≥80% predicted.
GOLD 2 - moderate: 50% ≤ FEV1 <80% predicted.
GOLD 3 - severe: 30% ≤ FEV1 <50% predicted.

38
Q

What are the non-pharmacological treatment options for management of COPD ?

A

smoking cessation +/- nicotine/bupoprion

immunisation- influenza/pneumococcal

physical activity

oxygen - domiciliary

venesection

lung volume reduction surgery

39
Q

What are the pharmacological treatment options for management of COPD?

A

SAMA/LAMA- ipatropium/tiotropium

SABA/LABA- salbutamol/salmeterol

LAMA-LABA- glycopyrronium/indacaterol

LABA-ICS- salmeterol/fluticasone

PDE4I- roflumilast
Mucolytic - carbocisteine (break down mucous)

SAMA- short acting muscarinic antagonist
LAMA- long acting muscarinic antagonist

SABA- short acting beta agonist
LABA- long acting beta agonist

ICS- inhaled corticosteroids

40
Q

Fluticasone, a novel steroid, is much stronger than beclamethasone. True or false

A

true

41
Q

What is the long term side effect of taking synthetic steroids?

A

adrenal insufficiency
stops natural production of adrenal hormones (catecholamines, aldosterone)

42
Q

What pharmacological interventions are used for the treatment of stable COPD?

A

broncodilators
beta agonist inhaler - salbutamol and terbutaline.
Antimuscarinic inhalers e.g. ipatropium

43
Q

What are the most common agents in blue inhalers?

A

salbutamol
terbutaline

44
Q

The effects of long acting bronchodilator inhalers are similar to those of short acting bronchodilator inhalers. What is the difference?

A

each dose of long acting bronchodilator inhalers can last up to 12 hour

long acting bronchodilators include LAMA and LABA

45
Q

When are long acting bronchodilator inhalers indicated?

A

if symptoms remain troublesome despite taking a short acting bronchodilator

46
Q

Give an example of SABA

A

salbutamol

47
Q

Give an example of a SAMA

A

ipatropium

48
Q

Give an example of a LAMA

A

Tiotropium

49
Q

Give examples of LABA

A

salmeterol
formoterol
indicaterol

50
Q

What is the only long-acting antimuscarinic inhaler?

A

Tiotropium

51
Q

Inhaled corticosteroids are only licensed in COPD in combination with…

A

LABA
long acting beta agonist e.g. salmeterol

52
Q

What is the aim of ICS therapy in COPD?

A

inflammation plays a central role in COPD (inflammation of bronchi walls, inflammation induced secretion of proteases) therefore ICS is aimed and halting and reversing inflammation

53
Q

What is the effect of ICS therapy on COPD?

A

decrease the rate of exarcebation
improve response to bronchodilators
decrease dyspnoea in stable COPD

54
Q

Outline the treatment of acute COPD

A

nebulised high dose of salbutamol (SABA) and ipatropium (SAMA)

oral prednisolone

antibiotic (amoxycillin/doxycycline) if infection

24-28% O2 titrated against PaO2/PaCO2

Physio to aid sputum expectoration (to aid coughing)

Non invasive ventilation to allow higher FiO2 (CPAP)-continuous positive airway pressure

ITU intubated assisted ventilation only if reversible component (e.g. pneumonia)

55
Q

What is the function of CPAP?

A

(continuous positive airway pressure)

prevents the collapse of the airways as it maintains the pressure in them

it is very difficult to inflate already collapsed airways

56
Q

Outline the differences between asthma and COPD

A

Asthma:
non smokers
allergic
early/late onset
intermittent symptoms
non productive cough
non progressive
eosiniophilic inflammation
diurnal variability (varies during day)
good corticosteroid response
good bronchodilator response
preserved FVE and TLCO (total lung capacity(
normal gas exchange

COPD:
Smokers
non- allergic
late onset
chronic symptoms
productive cough
progressive decline
neutrophilic inflammation (release proteases)
no diurnal variability (does not vary during the day)
poor corticosteroid response
poor bronchodilator response
reduced FVC and TLCO
impaired gas exchange

57
Q

What is a pink puffer? How can you identify them?

A

pin puffers work hard to maintain the partial pressure of O2

They tend to have barrell shaped, hyperinflated chests and breathe through pursed lips

Breathing through pursed lips allows them to create pressure preventing the collapse of their lungs

58
Q

What are blue bloaters?

A

Blue bloaters are blue due to hypoxia and polycythaemia

Polycythaemia due to compensatory overproduction of RBCs which reduces production of other blood cells. Increases viscocity of the blood

blue bloaters are often obese and have oedema

They are dependent on their hypoxia for their respiratory drive. Lack of oxygen keeps the lungs working to keep up with oxygen demand

59
Q

What is contraindicated management of blue bloater COPD patients ?

A

giving large amounts of oxygen
oxygen should be delivered at very gradual levels

Oxygen delivery will deprive then of their respiratory drive leading to significant hypercapnia (increased partial pressure of carbondioxide) and thus an acid-base imbalance

60
Q

List problems to consider in COPD patients

A

risk of infection (stagnant mucous)
chronic lung disease- cor pulmonale and heart failure
cough, sputum and resistance to antibiotics
emphysema- difficulty breathing when lying flat!

heart failure
treatment and side effects
steroids- ICS especially fluticasone (MRONJ)
Oxygen- hypoxic drive/respiratory drive

61
Q

What are some outpatient COPD considerations?

A

steroids
position of patient- do not lie emphysema patient flat; harder for them to breathe
halitosis - sweet smell of pseudomonas
pink puffers and blue bloaters
candidal infection (ICS)

62
Q

COPD rarely occurs in isolation. True or false
What other smoking related diseases can be caused?

A

True
ischaemic heart disease

HHD 2 (37 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions